How many insider trades does FilingIQ track for CALC?

FilingIQ tracks 166 Form 4 insider transactions for CALC (CalciMedica, Inc.), covering filings from Mar 20, 2023 onwards. 5 of those were filed in the last 90 days.

Are CALC insiders net buyers or net sellers?

Across the full Form 4 history for CALC, 118 transactions (71%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CALC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CALC in?

CalciMedica, Inc. (CALC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.07M.

CALC insider trading

NasdaqCM Healthcare

CalciMedica, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

166

Last 90 days

Buys / sells

71% / 1%

Market cap

$9.07M

About CalciMedica, Inc.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Company website: calcimedica.com

CALC insider activity at a glance

FilingIQ has scored 166 insider transactions for CALC since Mar 20, 2023. The most recent filing in our index is dated Jun 25, 2026.

Across the full history, 118 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CALC insider trades is 54.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CALC trades on FilingIQ Raw filings on SEC EDGAR

Latest CALC Form 4 filings

Bardin Stephen Chief Financial Officer

P Jun 26, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 234

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for CALC?: FilingIQ tracks 166 Form 4 insider transactions for CALC (CalciMedica, Inc.), covering filings from Mar 20, 2023 onwards. 5 of those were filed in the last 90 days.
Are CALC insiders net buyers or net sellers?: Across the full Form 4 history for CALC, 118 transactions (71%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CALC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CALC in?: CalciMedica, Inc. (CALC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $9.07M.

Methodology & sources

Every CALC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.